Pacific Biosciences of California, Inc. Amortization of Debt Discount (Premium)
Pacific Biosciences of California, Inc. (PACB) reported Amortization of Debt Discount (Premium) of -$87.00 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2013-05-10
- Pacific Biosciences of California, Inc. amortization of debt discount (premium) for the quarter ending 2013-03-31 was -$87.00K.
| Period end | Amortization of Debt Discount (Premium) 3 month |
|---|---|
| 2013-03-31 | -$87.00K 10-Q · filed 2013-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |